微针在局部获得的低黑色素质症:一个随机对照试验
Khaled Elhoshy1, Julbahar Ibrahim, Vanessa Hafez
1All authors are affiliated with the Department of Dermatology, Faculty of Medicine, Cairo University, Egypt.
概括
微针切割在治疗局部获得的低黑色素质症方面表现有前途,具有皮肤再颜色化的潜力. 为了提高疗效,建议对重复会话和全身影响进行进一步的研究.
科学领域:
- 皮肤病学 皮肤病学
- 再生医学是一种再生医学.
背景情况:
- 获得的局部性低颜色呈现了治疗方面的挑战.
- 微针法是一种微创的技术,可以促进黑色素的产生,并减少停机时间和痕风险.
研究的目的:
- 评估微针在治疗局部获得的低颜色素化的有效性和安全性.
- 评估患者和医生的满意度以及皮肤再颜色化的客观措施.
主要方法:
- 一项随机对照试验,涉及20名患有局部获得性低颜色变质的患者.
- 病变用单次1.5毫米微针治疗或不治疗.
- 在3个月后评估的结果包括外围色,患者满意度,表面色等级,VESTA和改善的全球评估 (GAI).
主要成果:
- 微针处理的结果与外围制中没有治疗组的结果相似 (80%与85%相比).
- 医生GAI (37.5%对33.33%) 和VESTA (37.5%对29%) 赞成微针.
- 两组都经历了表面色的中位数+3度的增加,在两只手臂中50%的患者GAI.
结论:
- 中深微针是各种皮肤纹理局部获得的低颜色化的一种可行的治疗选择.
- 每隔1-2个月重复进行微针接种可能会改善覆盖范围.
- 微针的潜在系统效应需要进一步研究.
相关概念视频
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.